BOLDBoundless Bio Inc. Common Stock
3.000USD+4.90%Mkt Cap: 68.24M $P/E: —3d ago
Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940,…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap68.24M $
Enterprise Value-6.66M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-58.20M $
Revenue/Share—
Last Price3.000 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.96
PEG—
EV/EBITDA0.10
EV/Revenue—
P/S—
P/B0.99
EPS (TTM)-2.89
EPS (Forward)-0.98
52W Range
0.961099% of range3.020
52W High3.020 USD
52W Low0.9610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-58.99%
ROA-37.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.66M $
CapEx (TTM)546.00K $
FCF Margin—
FCF Yield-44.77%
Net Debt-72.63M $
Net Debt/EBITDA1.13
Balance Sheet
Debt/Equity0.50
Current Ratio9.48
Quick Ratio9.35
Book Value/Sh2.936 USD
Cash/Share3.193 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+33.3%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.22.75M
Float16.08M
Insiders11.21%
Institutions67.26%
Short Interest
Short Ratio1.0d
Short % Float1.66%
Short % Out.1.00%
Shares Short223.82K
Short (prev mo.)188.95K
Technical
SMA 502.406 (+24.7%)
SMA 2001.546 (+94.0%)
Beta0.38
S&P 52W Chg18.16%
Avg Vol (30d)240.36K
Avg Vol (10d)279.18K
Technical Indicators
RSI (14)76.9
MACD0.1491
MACD Signal0.1477
MACD Hist.+0.0014
BB Upper3.036 USD
BB Middle2.699 USD
BB Lower2.361 USD
BB Width24.99%
ATR (14)0.1316 USD
Vol Ratio (20d)0.59x